Guannan Wu

1.4k total citations
52 papers, 1.1k citations indexed

About

Guannan Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Guannan Wu has authored 52 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Pulmonary and Respiratory Medicine and 14 papers in Oncology. Recurrent topics in Guannan Wu's work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Cancer-related molecular mechanisms research (6 papers). Guannan Wu is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Cancer-related molecular mechanisms research (6 papers). Guannan Wu collaborates with scholars based in China, United States and Hong Kong. Guannan Wu's co-authors include Yingshui Yao, Xiaoling Gu, Yong Song, Tangfeng Lv, Junli Zeng, Xuefei Shi, Dongmei Yuan, Qingqing Zhu, Yong Song and Xuequan Yao and has published in prestigious journals such as PLoS ONE, ACS Applied Materials & Interfaces and Free Radical Biology and Medicine.

In The Last Decade

Guannan Wu

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guannan Wu China 19 521 339 209 197 142 52 1.1k
Pei Li China 20 405 0.8× 178 0.5× 270 1.3× 175 0.9× 117 0.8× 89 1.1k
Weihong Jiang China 23 583 1.1× 255 0.8× 187 0.9× 180 0.9× 202 1.4× 109 1.5k
Wei Qian China 23 738 1.4× 348 1.0× 201 1.0× 184 0.9× 176 1.2× 112 1.8k
Yimin Zhang China 17 272 0.5× 232 0.7× 207 1.0× 402 2.0× 231 1.6× 100 1.2k
Ni Zeng China 19 451 0.9× 262 0.8× 295 1.4× 144 0.7× 109 0.8× 59 1.0k
Liming Cao China 18 360 0.7× 197 0.6× 229 1.1× 188 1.0× 108 0.8× 93 950
Min Ye China 21 434 0.8× 120 0.4× 210 1.0× 224 1.1× 139 1.0× 59 1.3k
Chenguang Ding China 19 464 0.9× 227 0.7× 199 1.0× 65 0.3× 210 1.5× 84 1.2k
Puxun Tian China 17 355 0.7× 210 0.6× 164 0.8× 104 0.5× 248 1.7× 53 1.0k
Jie Jiang China 17 299 0.6× 133 0.4× 224 1.1× 87 0.4× 171 1.2× 75 858

Countries citing papers authored by Guannan Wu

Since Specialization
Citations

This map shows the geographic impact of Guannan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guannan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guannan Wu more than expected).

Fields of papers citing papers by Guannan Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guannan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guannan Wu. The network helps show where Guannan Wu may publish in the future.

Co-authorship network of co-authors of Guannan Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Guannan Wu. A scholar is included among the top collaborators of Guannan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guannan Wu. Guannan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Jiayan, Yueyue Song, Yingshui Yao, et al.. (2024). Co-Delivery of VEGF siRNA and THPP via Metal–Organic Framework Reverses Cisplatin-Resistant Non-Small Cell Lung Cancer and Inhibits Metastasis through a MUC4 Regulating Mechanism. ACS Applied Materials & Interfaces. 16(42). 56910–56925. 4 indexed citations
2.
Chen, Che, et al.. (2024). Knockdown of TRIP13 inhibits gastric cancer stemness and cisplatin resistance by regulating FBXW7/ENO1 axis. Tropical Journal of Pharmaceutical Research. 23(1). 27–35.
3.
Wang, Zimu, et al.. (2024). A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancer. International Immunopharmacology. 137. 112478–112478. 1 indexed citations
4.
Chen, Jiayan, C. Xu, Qian Wang, et al.. (2023). Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study. Lung Cancer. 183. 107315–107315. 6 indexed citations
5.
Ni, Juan, Qiqi Wu, Guannan Wu, et al.. (2023). Discharge Against Medical Advice After Hospitalization for Sepsis: Predictors, 30-Day Readmissions, and Outcomes. Journal of Emergency Medicine. 65(5). e383–e392. 2 indexed citations
6.
Wu, Xiaoyu, et al.. (2022). Mechanisms of cancer cell killing by metformin: a review on different cell death pathways. Molecular and Cellular Biochemistry. 478(1). 197–214. 32 indexed citations
7.
8.
Li, Xinying, Guannan Wu, Cen Chen, et al.. (2021). Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion. Frontiers in Immunology. 12. 760683–760683. 14 indexed citations
9.
Wu, Zhenfeng, Kun Zou, Guannan Wu, et al.. (2020). A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients. Digestive Diseases and Sciences. 66(5). 1673–1682. 36 indexed citations
10.
Qian, Hong, et al.. (2020). Neutrophil-derived long noncoding RNA IL-7R predicts development of multiple organ dysfunction syndrome in patients with trauma. European Journal of Trauma and Emergency Surgery. 48(3). 1545–1553. 4 indexed citations
11.
Wu, Guannan, Xiaoling Gu, Dongmei Yuan, et al.. (2019). Diagnosis status and pathological diagnosis derived treatment of elderly lung cancer patients over 75 years old. Translational Cancer Research. 8(1). 87–95. 1 indexed citations
12.
Wu, Guannan, Qingqing Zhu, Junli Zeng, et al.. (2019). Extracellular mitochondrial DNA promote NLRP3 inflammasome activation and induce acute lung injury through TLR9 and NF-κB. Journal of Thoracic Disease. 11(11). 4816–4828. 79 indexed citations
13.
Wu, Guannan, Jiayun Liu, Zhenfeng Wu, Xiaoyu Wu, & Xuequan Yao. (2017). MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R. Oncology Letters. 14(3). 3215–3222. 31 indexed citations
14.
Yuan, Dongmei, Jianya Zhang, Yingshui Yao, et al.. (2017). The pulmonary nodule “discovered” by pneumonia: a case report. Translational Lung Cancer Research. 6(1). 92–96. 1 indexed citations
15.
16.
17.
Gu, Xiaoling, Guannan Wu, Yingshui Yao, et al.. (2015). Intratracheal administration of mitochondrial DNA directly provokes lung inflammation through the TLR9–p38 MAPK pathway. Free Radical Biology and Medicine. 83. 149–158. 69 indexed citations
18.
Wu, Guannan, Ming Zhao, Xiaoling Gu, et al.. (2014). The effect of P2X7 receptor 1513 polymorphism on susceptibility to tuberculosis: A meta-analysis. Infection Genetics and Evolution. 24. 82–91. 28 indexed citations
19.
Yao, Yingshui, Xiwen Gu, Haibo Liu, et al.. (2014). Metadherin regulates proliferation and metastasis via actin cytoskeletal remodelling in non-small cell lung cancer. British Journal of Cancer. 111(2). 355–364. 40 indexed citations
20.
Gu, Xiaoling, Yingshui Yao, Guannan Wu, et al.. (2013). The Plasma Mitochondrial DNA Is an Independent Predictor for Post-Traumatic Systemic Inflammatory Response Syndrome. PLoS ONE. 8(8). e72834–e72834. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pei Li Breakdown of academic impact, for papers by Weihong Jiang Breakdown of academic impact, for papers by Wei Qian Breakdown of academic impact, for papers by Yimin Zhang Breakdown of academic impact, for papers by Ni Zeng Breakdown of academic impact, for papers by Liming Cao Breakdown of academic impact, for papers by Min Ye Breakdown of academic impact, for papers by Chenguang Ding Breakdown of academic impact, for papers by Puxun Tian Breakdown of academic impact, for papers by Jie Jiang
Rankless by CCL
2026